CSIMarket
 


Kymera Therapeutics Inc   (KYMR)
Other Ticker:  
 
 

KYMR's Net Income Growth by Quarter and Year

Kymera Therapeutics Inc 's Net Income results by quarter and year




KYMR Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -28.58 -7.99 0.00
III Quarter September -43.00 -24.66 0.00 0.00
II Quarter June -40.26 -13.08 0.00 0.00
I Quarter March -36.68 7.99 0.00 0.00
FY   -119.94 -58.33 -7.99 0.00



KYMR Net Income third quarter 2022 Y/Y Growth Comment
Kymera Therapeutics Inc in the third quarter 2022 recorded net loss of $ -43.00 millions.

According to the results reported in the third quarter 2022, Kymera Therapeutics Inc achieved the best Net Income growth in Biotechnology & Pharmaceuticals industry. While Kymera Therapeutics Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter 2022.




KYMR Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Kymera Therapeutics Inc 's third quarter 2022 Net Income $ -43.00 millions KYMR's Income Statement
Kymera Therapeutics Inc 's third quarter 2021 Net Income $ -24.66 millions Quarterly KYMR's Income Statement
New: More KYMR's historic Net Income Growth >>


KYMR Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Kymera Therapeutics Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KYMR's III. Quarter Q/Q Net Income Comment
Current results of -43.00 millions by Kymera Therapeutics Inc come out even more unfavourable compare to the -40.26 millions in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Kymera Therapeutics Inc achieved highest sequential Net Income growth. While Kymera Therapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KYMR's III. Quarter Q/Q Net Income Comment
Current accomplishment of -43.00 millions by Kymera Therapeutics Inc appear even worse considering the -40.26 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Kymera Therapeutics Inc achieved highest sequential Net Income growth. While Kymera Therapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Kymera Therapeutics Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
Cumulative Net Income 12 Months Ending $ -148.53 $ -130.18 $ -103.00 $ -58.33 $ -37.74
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Kymera Therapeutics Inc ' has realized cumulative trailing twelve months net loss of $ -149 millions in the Sep 30 2022 period.
The business is worsening as the cumulative net loss is becoming larger from $ -130.18 millions in the twelve months ending a quarter before and $ -40.26 millions for the twelve months ending in the quarter a year ago Alejandro Brown mentioned.

Kymera Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Kymera Therapeutics Inc ' has realized cumulative trailing twelve months net loss of $ -149 millions in the Sep 30 2022 period.
The business is getting worse as the cumulative net loss is getting bigger from $ -130.18 millions for the period from Jun 30 2022 to Jun 30 2021 and $ -40.26 millions from the TTM period ending Jun 30 2021.

Kymera Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Pharmaceuticals Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
KYMR's Net Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for KYMR's Competitors
Net Income Growth for Kymera Therapeutics Inc 's Suppliers
Net Income Growth for KYMR's Customers

You may also want to know
KYMR's Annual Growth Rates KYMR's Profitability Ratios KYMR's Asset Turnover Ratio KYMR's Dividend Growth
KYMR's Roe KYMR's Valuation Ratios KYMR's Financial Strength Ratios KYMR's Dividend Payout Ratio
KYMR's Roa KYMR's Inventory Turnover Ratio KYMR's Growth Rates KYMR's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2022
Innoviva Inc 123.43%$ 123.435 millions
Catalyst Pharmaceuticals Inc 120.23%$ 120.234 millions
Bausch Health Companies Inc 110.99%$ 110.995 millions
Lsi Industries Inc 99.87%$ 99.872 millions
Abiomed Inc 86.35%$ 86.352 millions
Stryker Corp86.30%$ 86.301 millions
Universal Security Instruments Inc86.27%$ 86.267 millions
American Shared Hospital Services83.33%$ 83.333 millions
Carlisle Companies Incorporated79.24%$ 79.240 millions
Vir Biotechnology Inc 58.76%$ 58.757 millions
United Therapeutics Corporation47.08%$ 47.081 millions
Dexcom Inc 42.74%$ 42.736 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OXUS's Profile

Stock Price

OXUS's Financials

Business Description

Fundamentals

Charts & Quotes

OXUS's News

Suppliers

OXUS's Competitors

Customers & Markets

Economic Indicators

OXUS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071